{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:11:48Z","timestamp":1723075908650},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>A number of trials related to critical care pharmacotherapy were published in 2022. We aimed to summarize the most influential publications related to the pharmacotherapeutic care of critically ill patients in 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>PubMed\/Medical Literature Analysis and Retrieval System Online and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Randomized controlled trials, prospective studies, or systematic review\/meta-analyses of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2022, and December 31, 2022, were included in this article.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included and stratified into clinical domains based upon consistent themes. Consensus was obtained on the most influential publication within each clinical domain utilizing an a priori defined three-round modified Delphi process with the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update yielded a total of 704 articles, of which 660 were excluded. The remaining 44 articles were stratified into the following clinical domains: emergency\/neurology, cardiovascular, gastroenterology\/fluids\/nutrition, hematology, infectious diseases\/immunomodulation, and endocrine\/metabolic. The final article selected from each clinical domain was summarized following a three-round modified Delphi process and included three randomized controlled trials and three systematic review\/meta-analyses. Article topics summarized included dexmedetomidine versus other sedatives during mechanical ventilation, beta-blocker treatment in the critically ill, restriction of IV fluids in septic shock, venous thromboembolism prophylaxis in critically ill adults, duration of antibiotic therapy for <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic> ventilator-associated pneumonia, and low-dose methylprednisolone treatment in severe community-acquired pneumonia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>This concise review provides a perspective on articles published in 2022 that are relevant to the pharmacotherapeutic care of critically ill patients and their potential impact on clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000981","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T14:03:10Z","timestamp":1695650590000},"page":"e0981","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Major Publications in the Critical Care Pharmacotherapy Literature: 2022"],"prefix":"10.1097","volume":"5","author":[{"given":"Payal K.","family":"Gurnani","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Memorial Hermann The Woodlands Medical Center, The Woodlands, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Barlow","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Memorial Hermann The Woodlands Medical Center, The Woodlands, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Boling","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Division of Critical Care Medicine, University of Kentucky, Lexington, KY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence W.","family":"Busse","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Johns Creek, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Diaz-Gomez","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Texas Heart Institute, Baylor College of Medicine, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Ford","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Florida, Gainesville, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle A.","family":"Gibson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Section of Critical Care Medicine, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mount Sinai West, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M.","family":"Rivosecchi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, UPMC Presbyterian Hospital, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Spezzano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Kentucky HealthCare, Lexington, KY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Thornton","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saraschandra","family":"Vallabhajosyula","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey J.","family":"Witenko","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, New York-Presbyterian Hospital, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology and Pharmacy, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4300\/JGME-D-18-00621.1","article-title":"Staying up to date and managing information overload.","volume":"10","author":"Maggio","year":"2018","journal-title":"J Grad Med Educ"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00134-023-07073-0","article-title":"Publication hyper-inflation in the field of intensive care.","volume":"49","author":"Tsutsumi","year":"2023","journal-title":"Intensive Care Med"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1161\/STROKEAHA.121.036141","article-title":"Keeping up with the medical literature: Why, how, and when?","volume":"52","author":"Kamtchum-Tatuene","year":"2021","journal-title":"Stroke"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2146\/ajhp130303","article-title":"Major publications in the critical care pharmacotherapy literature: February 2012 through February 2013.","volume":"71","author":"Turck","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2146\/ajhp140241","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2013.","volume":"72","author":"Rech","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2146\/ajhp150220","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2014.","volume":"72","author":"Day","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2146\/ajhp160144","article-title":"Major publications in the critical care pharmacotherapy literature in 2015.","volume":"74","author":"Wong","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcrc.2017.09.178","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2016.","volume":"43","author":"Horner","year":"2018","journal-title":"J Crit Care"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcrc.2018.02.012","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2017.","volume":"45","author":"Hammond","year":"2018","journal-title":"J Crit Care"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcrc.2019.04.029","article-title":"Major publications in critical care pharmacotherapy literature in 2018.","volume":"52","author":"Newsome","year":"2019","journal-title":"J Crit Care"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcrc.2020.12.018","article-title":"Major publications in the critical care pharmacotherapy literature: 2019.","volume":"62","author":"Condeni","year":"2021","journal-title":"J Crit Care"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"e0590","DOI":"10.1097\/CCE.0000000000000590","article-title":"Major publications in the critical care pharmacotherapy literature: 2020.","volume":"3","author":"Bissell","year":"2021","journal-title":"Crit Care Explor"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"e0823","DOI":"10.1097\/CCE.0000000000000823","article-title":"Major publications in the critical care pharmacotherapy literature: 2021.","volume":"4","author":"Wieruszewski","year":"2022","journal-title":"Crit Care Explor"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-022-06712-2","article-title":"Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: A systematic review and meta-analysis of randomized trials.","volume":"48","author":"Lewis","year":"2022","journal-title":"Intensive Care Med"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"6219678","DOI":"10.1155\/2021\/6219678","article-title":"Incidence and risk factors of delirium in the intensive care unit: A prospective cohort.","volume":"2021","author":"Rahimi-Bashar","year":"2021","journal-title":"Biomed Res Int"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/CCM.0000000000003482","article-title":"Caring for critically ill patients with the ABCDEF bundle: Results of the ICU liberation collaborative in over 15,000 adults.","volume":"47","author":"Pun","year":"2019","journal-title":"Crit Care Med"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bja.2019.08.026","article-title":"Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.","volume":"123","author":"Gao","year":"2019","journal-title":"Br J Anaesth"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201710-1995OC","article-title":"Low-dose nocturnal dexmedetomidine prevents ICU delirium. A randomized, placebo-controlled trial.","volume":"197","author":"Skrobik","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2012.304","article-title":"Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials.","volume":"307","author":"Jakob","year":"2012","journal-title":"JAMA"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","article-title":"Early sedation with dexmedetomidine in critically ill patients.","volume":"380","author":"Shehabi","year":"2019","journal-title":"N Engl J Med"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-5151.190656","article-title":"Predictors of dexmedetomidine-associated hypotension in critically ill patients.","volume":"6","author":"Gerlach","year":"2016","journal-title":"Int J Crit Illn Inj Sci"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1080\/07853890.2022.2098376","article-title":"Beta-blocker treatment in the critically ill: A systematic review and meta-analysis.","volume":"54","author":"Heliste","year":"2022","journal-title":"Ann Med"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13054-015-0803-2","article-title":"\u03b2-blockers in critically ill patients: From physiology to clinical evidence.","volume":"19","author":"Coppola","year":"2015","journal-title":"Crit Care"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/SHK.0b013e3181863689","article-title":"Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model.","volume":"31","author":"Hagiwara","year":"2009","journal-title":"Shock"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/TA.0000000000001747","article-title":"Beta blockers in critically ill patients with traumatic brain injury: Results from a multicenter, prospective, observational American Association for the Surgery of Trauma study.","volume":"84","author":"Ley","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajem.2017.11.013","article-title":"The influence of esmolol on septic shock and sepsis: A meta-analysis of randomized controlled studies.","volume":"36","author":"Liu","year":"2018","journal-title":"Am J Emerg Med"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial.","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40360-018-0213-6","article-title":"Association between \u03b2-blocker use and mortality in critically ill patients: A nested cohort study.","volume":"19","author":"Al Harbi","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jacc.2021.07.006","article-title":"Beta-blockers in the critically ill: Friend or foe?","volume":"78","author":"Senussi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","article-title":"Restriction of intravenous fluid in ICU patients with septic shock.","volume":"386","author":"Meyhoff","year":"2022","journal-title":"N Engl J Med"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00134-016-4573-3","article-title":"Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: A systematic review and meta-analysis.","volume":"43","author":"Silversides","year":"2017","journal-title":"Intensive Care Med"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"e0219","DOI":"10.1097\/CCE.0000000000000219","article-title":"A higher fluid balance in the days after septic shock reversal is associated with increased mortality: An observational cohort study.","volume":"2","author":"van Mourik","year":"2020","journal-title":"Crit Care Explor"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2017.10913","article-title":"Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: A randomized clinical trial.","volume":"318","author":"Andrews","year":"2017","journal-title":"JAMA"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00134-016-4500-7","article-title":"Restricting volumes of resuscitation fluid in adults with septic shock after initial management: The CLASSIC randomised, parallel-group, multicentre feasibility trial.","volume":"42","author":"Hjortrup","year":"2016","journal-title":"Intensive Care Med"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension.","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"R36-20240807","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13054-017-1726-x","article-title":"Effect sizes in ongoing randomized controlled critical care trials.","volume":"21","author":"Ridgeon","year":"2017","journal-title":"Crit Care"},{"key":"R37-20240807","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMe2206160","article-title":"Intravenous fluids in septic shock - more or less?","volume":"386","author":"McIntyre","year":"2022","journal-title":"N Engl J Med"},{"key":"R38-20240807","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chest.2021.08.050","article-title":"VTE prophylaxis in critically ill adults: A systematic review and network meta-analysis.","volume":"161","author":"Fernando","year":"2022","journal-title":"Chest"},{"key":"R39-20240807","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2147\/RMHP.S272852","article-title":"Venous thromboembolism risk and thromboprophylaxis assessment in surgical patients based on Caprini risk assessment model.","volume":"13","author":"Tadesse","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"R40-20240807","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/01.CCM.0000165962.16682.46","article-title":"Give your patient a fast hug (at least) once a day.","volume":"33","author":"Vincent","year":"2005","journal-title":"Crit Care Med"},{"key":"R41-20240807","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.","volume":"164","author":"Lyman","year":"2018","journal-title":"Thromb Res"},{"key":"R42-20240807","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00134-022-06690-5","article-title":"Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: A randomized, controlled, open-label trial.","volume":"48","author":"Bougl\u00e9","year":"2022","journal-title":"Intensive Care Med"},{"key":"R43-20240807","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R44-20240807","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial.","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"R45-20240807","first-page":"CD007577","article-title":"Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.","volume":"2015","author":"Pugh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R46-20240807","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.annfar.2008.10.021","article-title":"[Duration of antibiotic therapy for ventilator-associated pneumonia: Comparison of 7 and 10 days. A pilot study].","volume":"28","author":"Fekih Hassen","year":"2009","journal-title":"Ann Fr Anesth Reanim"},{"key":"R47-20240807","doi-asserted-by":"crossref","first-page":"e41290","DOI":"10.1371\/journal.pone.0041290","article-title":"Early-onset ventilator-associated pneumonia in adults randomized clinical trial: Comparison of 8 versus 15 days of antibiotic treatment.","volume":"7","author":"Capellier","year":"2012","journal-title":"PLoS One"},{"key":"R48-20240807","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med"},{"key":"R49-20240807","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamainternmed.2019.1438","article-title":"Effectiveness of a bundled intervention including adjunctive corticosteroids on outcomes of hospitalized patients with community-acquired pneumonia: A stepped-wedge randomized clinical trial.","volume":"179","author":"Lloyd","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R50-20240807","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial.","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"R51-20240807","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia.","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"R52-20240807","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study.","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R53-20240807","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: A systematic review and meta-analysis.","volume":"163","author":"Siemieniuk","year":"2015","journal-title":"Ann Intern Med"},{"key":"R54-20240807","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/cix801","article-title":"Corticosteroids in patients hospitalized with community-acquired pneumonia: Systematic review and individual patient data metaanalysis.","volume":"66","author":"Briel","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R55-20240807","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T01:05:40Z","timestamp":1722992740000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000981","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2023,9,22]]}}}